2653 monitored
← Actor desksRead-only · existing recordsClassic graph view ↗

Sentinels / Actor desk

Lilly Zepbound

person · Registry status: unverified

c9668d74-da56-5f96-b24b-63dd7b5ad334

Evidence, not intent.

Public-source event mentions and stored signals. Adjacency does not establish causation, coordination, or an actor's position.

No claim of complete coverage or live monitoring.

Observation window

UTC dates, inclusive · maximum 90 days. Applies to events and anomalies only.

Recent observations / timeline

The source record

22 distinct events shown, newest first. Headlines may be generated summaries; inspect the source before repeating a claim.

  1. Beauty giants target ‘Ozempic face’ as boom in obesity drugs opens new market - BusinessWorld Online

    Recorded role: co mention · TAX_FNCACT_PHYSICIAN

    Open source ↗
  2. How are beauty brands targeting “Ozempic face”?

    Recorded role: co mention · TAX_DISEASE_LOOSE_SKIN

    Open source ↗
  3. As the Market's Party Shrinks, Here's One Stock to Buy

    Recorded role: co mention · EPU_UNCERTAINTY

    Open source ↗
  4. freemalaysiatoday.com: Eli Lilly Zepbound, Novo Nordisk Ozempic, Torrent Pharmaceuticals (ideology, crisislex c03 wellbeing health)

    Recorded role: co mention · IDEOLOGY

    Open source ↗
  5. Getting health insurance from your job will be extra pricey for 2027

    Recorded role: co mention · WB_625_HEALTH_ECONOMICS_AND_FINANCE

    Open source ↗
  6. Getting health insurance from your job will be extra pricey for 2027

    Recorded role: co mention · TAX_FNCACT_WORKER

    Open source ↗
  7. Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market

    Recorded role: co mention · WB_1331_HEALTH_TECHNOLOGIES

    Open source ↗
  8. Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market

    Recorded role: co mention · TAX_WORLDMAMMALS_HUMAN

    Open source ↗
  9. Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market

    Recorded role: co mention · TAX_FNCACT_SURGEON

    Open source ↗
  10. Beauty giants target 'Ozempic face' amid new market

    Recorded role: co mention · TAX_DISEASE_GASTROINTESTINAL

    Open source ↗
  11. Beauty firms chase 'Ozempic face' market as weight-loss drugs boom

    Recorded role: co mention · SOC_POINTSOFINTEREST_COLLEGE

    Open source ↗
  12. Beauty firms chase 'Ozempic face' market as weight-loss drugs boom

    Recorded role: co mention · TAX_FNCACT_REGULATORS

    Open source ↗
  13. Beauty giants target ‘Ozempic face’ as boom in obesity drugs opens new market - KSEV Radio

    Recorded role: co mention · GENERAL_HEALTH

    Open source ↗
  14. Beauty firms chase 'Ozempic face' market as weight-loss drugs boom

    Recorded role: co mention · UNGP_AFFORDABLE_NUTRITIOUS_FOOD

    Open source ↗
  15. Rona inks deal worth up to $1.16B to license obesity drug | Pacific Coast Business Times

    Recorded role: co mention · TAX_DISEASE_METABOLIC_DISEASES

    Open source ↗
  16. Roche extends China deal streak with $1B pact for RNAi obesity drug

    Recorded role: co mention · TAX_DISEASE_DISEASE

    Open source ↗
  17. Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing. Is Now the Time to Buy This Biotech Stock? | The Motley Fool

    Recorded role: co mention · TAX_FNCACT_CANDIDATE

    Open source ↗
  18. Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing. Is Now the Time to Buy This Biotech Stock? | The Motley Fool

    Recorded role: co mention · CRISISLEX_C03_WELLBEING_HEALTH

    Open source ↗
  19. Americans Paying for Cheap Online Semaglutide May Be Sending Money to Vendors That Also List Fentanyl Precursors

    Recorded role: co mention · TAX_FNCACT_DOCTOR

    Open source ↗
  20. Where Will Eli Lilly Stock Be in 5 Years? Follow the Pipeline Beyond Zepbound | The Motley Fool

    Recorded role: co mention · UNGP_FORESTS_RIVERS_OCEANS

    Open source ↗
  21. Here Are My Top 4 Stocks to Buy in October | The Motley Fool

    Recorded role: co mention · AFFECT

    Open source ↗
  22. Here Are My Top 4 Stocks to Buy in October - AOL

    Recorded role: co mention · WB_678_DIGITAL_GOVERNMENT

    Open source ↗

Signals to inspect

Anomalies

Latest 3 in the selected window (up to 10). Detector output, not verified conclusions.

high · new connection

New connection: 13 previously unseen co-actor(s) detected (known network: 30)

low · new connection

New connection: 1 previously unseen co-actor(s) detected (known network: 29)

high · new connection

New connection: 3 previously unseen co-actor(s) detected (known network: 21)

Narrative context

Unresolved threads

Latest 20 at most, across all dates. Stored narratives require human review.

Stored connections

Relationships

Up to 50 records ordered by evidence count, across all dates. Co-mentions indicate association in source material, not affiliation or coordination.

Ask this desk

Desk analyst

Read-only questions about Lilly Zepbound's stored record. Answers cite only records retrieved for that turn; a citation chip opens the existing inspection view. Absence of matches is not evidence of inactivity.

Operator sign-in is required. Sign in

Identity is the existing actor registry record. Entity resolution and source coverage may be incomplete.